Apeloa Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Apeloa Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Northeast Pharmaceutical Group Co., Ltd.
sales of 7.38 billion Chinese Renmimbi [US$1.15 billion]
of which 55%
was Pharmaceutical Products),
KPC Pharmaceuticals Inc
(7.72 billion Chinese Renmimbi [US$1.20 billion]
of which 48%
was Drugs Wholesale and Retail), and
Zhejiang Medicine Co., Ltd.
(7.33 billion Chinese Renmimbi [US$1.14 billion]
of which 69%
During the first
quarter of 2021, sales at Apeloa Pharmaceutical Co Ltd totalled
1.95 billion Chinese Renmimbi.
an increase of 14.8%
from the 1.70 billion Chinese Renmimbi in sales at the company during the first quarter of 2020.
Apeloa Pharmaceutical Co Ltd reported sales of 7.88 billion Chinese Renmimbi (US$1.23 billion)
December of 2020.
increase of 9.3%
versus 2019, when the company's sales were 7.21 billion Chinese Renmimbi.
Sales at Apeloa Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 82%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
123.4% in 2020, from
12.57 million Chinese Renmimbi to 28.09 million Chinese Renmimbi.